跳至主要内容
临床试验/NCT06779669
NCT06779669终止不适用

Use of Alternative and Complementary Medicine by Colorectal Cancer Patients

University Hospital, Limoges1 个研究点 分布在 1 个国家目标入组 217 人开始时间: 2025年1月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
217
试验地点
1
主要终点
MAC using

研究概览

简要总结

Complementary and alternative medicine (CAM) is defined by the National Center for Complementary and Alternative Medicine as "a group of diverse medical and health systems, practices and products that are not currently considered part of conventional medicine" (Complementary, Alternative, or Integrative Health, n. d. 2012). Complementary medicine is used to complement conventional medicine, and alternative medicine is used instead of conventional medicine (Dy et al., 2004). These are two very different approaches, whose consequences for a cancer patient can be completely different. The use of CAM is steadily increasing in most countries. A study carried out in France in 2017 revealed that for half of CAM users, the diagnosis of cancer was one of the main factors that led patients to turn to CAM (Sarradon-Eck et al., 2017). CAM use was found to be significantly associated with younger age, female gender and higher education (Sarradon-Eck et al., 2017). The source of information about MAC was mainly friends/family and the media, while doctors and nurses played a succinct role in MAC information (Molassiotis et al., 2005). The most frequently cited reasons for using CAM were to improve their physical well-being, strengthen their bodies, improve their emotional well-being and relieve the side effects of treatment (Sarradon-Eck et al., 2020). Another study carried out in 2019 at nine centers in France showed that 45% of glioma patients had changed their eating habits after glioma diagnosis, 44% were on complementary treatment, mainly vitamins and dietary supplements, and 32% were using alternative medicine, mainly magnetism and acupuncture. A total of 68% reported using at least one of these approaches (Le Rhun et al., 2019). Another single-center study conducted in France in 2019 found that 83% of cancer patients used CAM (M et al., 2019). CAM included osteopathy, homeopathy, acupuncture, therapeutic touch, magnetism, naturopathy, cupping, Chinese medicine, reflexology and hypnosis. However, no studies have been carried out to assess the use of CAM among colorectal cancer (CRC) patients in France.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Over 18 years of age
  • •Diagnosed with colorectal cancer
  • •To be operated on between 2017 and 2022

排除标准

  • •The patient refuses to give consent to participate in the study
  • •Non-primary colorectal cancer (metastasis to the colon or rectum from another primary cancer; cancer originating in the appendix)
  • •Primary metastatic cancer other than colorectal cancer
  • •Discovery of cancer synchronous with colorectal cancer
  • •Guardianship or trusteeship
  • •Cognitive disorders (Alzheimer's, dementia, etc.)
  • •Severe psychiatric disorder (neurodevelopmental disorder, psychotic disorder, mood disorder, etc.) according to the specific DSM-5 and ICD-11 classifications
  • •Severe deafness (unable to answer questions during telephone interview)

研究组 & 干预措施

Complementary and alternative medicine user

Other

Selected patients will answer a questionnaire about their practice and habits with regard to alternative and complementary medicines. Of these patients, 12 will also complete an additional qualitative questionnaire.

干预措施: Questionnaire CAM (Other)

结局指标

主要结局

MAC using

时间窗: Month 2

Proportion of patients treated at Limoges University Hospital for colorectal cancer (CRC) using MACs

次要结局

  • Reasons of using MAC(month 2)
  • Effects perceived(month 2)
  • healthcare professionals' report on MAC(month 2)
  • Clinical factors(month 2)
  • Recurrence time(Month 2)
  • Quality of life(Month 2)
  • MAC information sources(month 2)
  • Demographic factors(Month 2)

研究者

发起方
University Hospital, Limoges
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验